Document: Medicinal products for human use: monthly figures - November 2025-2025/12/8

Document: Deadlines for submission of applications for orphan medicinal product designation to the EMA and corresponding COMP timetable for valid applications 2026-2027-2026/1/19

Page: Risk management requirements for elemental impurities in veterinary medicinal products - Scientific guideline-2026/2/20

Document: QRD Appendix V - Adverse-drug-reaction reporting details-2026/3/25

Document: List of eligible industry stakeholder organisations-2026/5/4

In Vitro Release Test Studies for Topical Drug Products Submitted in ANDAs (Draft)-2022/10/21

国家药监局药审中心关于发布《儿童用药沟通交流中Ⅰ类会议申请及管理工作细则（试行）》的通告-2023/4/18

Scientific guideline: Guideline on the calculation of dose factor to be submitted to the Union Product Database (UPD)-2023/10/13

Document: European Medicines Agency’s data protection notice for the processing of personal data contained in the Agency’s historical records selected for permanent preservation and opening to the public-2025/1/9

Document: Contact details of national competent authorities for requests of translation exemptions falling under Art. 63.3 of Directive 2001/83/EC and cases of shortages-2025/2/17